COSMO PHARMACEUTICALS NV (C43.DE) Stock Income Statement
Europe - Frankfurt Stock Exchange - FRA:C43 - NL0011832936 - Common Stock
48.8 EUR
-1.2 (-2.4%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 266.79M | 92.78M | 102.09M | 65.07M | 60.95M | |||
| Minority Interest Expense | 45.00K | -80.00K | -280.00K | -1.00K | 0.00 | |||
| Cost Of Goods | 45.36M | 39.34M | 40.49M | 32.98M | 27.62M | |||
| Gross Profit | 221.43M | 53.44M | 61.60M | 32.10M | 33.33M | |||
| Operating Expenses | 72.55M | 55.31M | 33.54M | 21.00M | 30.43M | |||
| Research and Development | 38.04M | 25.64M | 11.55M | 7.60M | 13.60M | |||
| Selling, General, and Administrative Expenses | 36.28M | 29.94M | 19.91M | 10.46M | 18.68M | |||
| Operating Income | 148.88M | -1.88M | 28.06M | 11.10M | 2.90M | |||
| Interest Income/Expense | 4.55M | -4.50M | -3.47M | 13.38M | -13.67M | |||
| Other Income/Expense | -67.00K | -118.00K | -113.00K | -481.00K | -168.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 4.00M | |||
| Income Before Taxes | 153.37M | -6.49M | 24.47M | 24.00M | -6.93M | |||
| Income Tax | 20.18M | 4.21M | 6.97M | 2.33M | 970.00K | |||
| Net Income | 133.24M | -10.78M | 17.23M | 21.67M | -7.90M | |||
| EBITDA | 161.17M | 9.97M | 41.91M | 18.47M | 8.94M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 8.14 | -0.67 | 1.05 | 1.28 | -0.55 | |||
| Non GAAP EPS | N/A | N/A | 1.05 | N/A | -0.55 | |||
| Statistics | ||||||||
| Gross Profit Margin | 83.00% | 57.60% | 60.34% | 49.32% | 54.69% | |||
| Profit Margin | 49.94% | -11.62% | 16.87% | 33.30% | -12.96% | |||
| Operating Profit Margin | 55.81% | -2.02% | 27.48% | 17.06% | 4.77% | |||
All data in EUR